Skip to main content
. 2017 Oct 19;6(4):239–246. doi: 10.1007/s13670-017-0223-z

Table 1.

Studies on PET compared to surgery alone

Ref., author Number of patients Therapy Follow-up Outcome ER status evaluated
[13] Fentiman et al. 164 Radical mastectomy or tamoxifen 20 mg daily Median of 10 years OS HR (95% CI) 1.11 (0.75–1.65)
PFS HR (95% CI) 0.55 (0.39–0.77)
No
[14] Kenny et al. 131 Wedge mastectomy or tamoxifen 40 mg daily Median of 5 years OS HR (95% CI) 1.06 (0.59–1.92)
PFS not calculated
No
[15, 16] Gazet et al. 200 Mastectomy or tamoxifen 20 mg daily 6 years OS HR (95% CI) 0.75 (0.44–1.26)
PFS not calculated
No
[5] Chakrabati et al. 131 Wedge mastectomy or tamoxifen 20 mg daily 20 years OS P = 0.4457
PFS P = <0.001
No

ER oestrogen receptor, OS overall survival, HR hazard ratio, CI confidence interval, PFS progression-free survival